Medikaloka Hermina (HEAL) Stock Overview
Operates a network of hospitals in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
HEAL passed our risk checks.
HEAL Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
PT Medikaloka Hermina Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp1,275.00 |
| 52 Week High | Rp1,775.00 |
| 52 Week Low | Rp920.00 |
| Beta | 0.011 |
| 1 Month Change | -2.67% |
| 3 Month Change | -11.76% |
| 1 Year Change | -3.77% |
| 3 Year Change | -11.15% |
| 5 Year Change | 54.73% |
| Change since IPO | 101.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEAL | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -0.8% | -2.6% | -6.9% |
| 1Y | -3.8% | 102.8% | 17.3% |
Return vs Industry: HEAL underperformed the ID Healthcare industry which returned 102.8% over the past year.
Return vs Market: HEAL underperformed the ID Market which returned 17.3% over the past year.
Price Volatility
| HEAL volatility | |
|---|---|
| HEAL Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in ID Market | 18.1% |
| 10% least volatile stocks in ID Market | 3.5% |
Stable Share Price: HEAL has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: HEAL's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 18,344 | H. Hasmoro | www.herminahospitals.com |
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, and dermatology and venereology. It also provides services in the areas of ophthalmology, clinical microbiology, pediatric neurology, occupational, radiation oncology, pulmonology, anatomical pathology, clinical pathology, anesthesiology, internal medicine, psychology, radiology, physical medicine and rehabilitation, neurology, sports specialist, aviation specialist, otorhinolaryngology, occupational therapy, and urology.
PT Medikaloka Hermina Tbk Fundamentals Summary
| HEAL fundamental statistics | |
|---|---|
| Market cap | Rp19.59t |
| Earnings (TTM) | Rp423.80b |
| Revenue (TTM) | Rp6.98t |
Is HEAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEAL income statement (TTM) | |
|---|---|
| Revenue | Rp6.98t |
| Cost of Revenue | Rp4.81t |
| Gross Profit | Rp2.17t |
| Other Expenses | Rp1.74t |
| Earnings | Rp423.80b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.58 |
| Gross Margin | 31.07% |
| Net Profit Margin | 6.07% |
| Debt/Equity Ratio | 46.4% |
How did HEAL perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/06 20:51 |
| End of Day Share Price | 2026/03/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PT Medikaloka Hermina Tbk is covered by 18 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Chandra | CGS International |
| Lakshmi Rowter | Citigroup Inc |
| Omar Abdulaziz | CLSA |